Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01908166 · ClinicalTrials.gov registry record · NA

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT01908166: Completed NA study, sponsored by Stanford University.

NCT01908166 is a NA study that has completed, run by Stanford University. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01908166, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.

Primary Outcome

Suspicious liver and kidney lesions will be analyzed separately on a per-lesion basis. Within each population, the strain ratio of cases and controls will be compared using the Wilcoxon rank sum test, and the analysis will be illustrated using the non-parametric receiver operating characteristic (ROC).

Interventions

  • PROCEDURE ultrasound elasticity imaging

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2014-01
Est. Completion 2016-11-01
Phase NA
Stanford University

1,744 total trials

What the finished NCT01908166 record still lists

NCT01908166 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which ultrasound elasticity imaging is the first listed.

NCT01908166 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01908166 about?

NCT01908166 is a clinical study titled "Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions". This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.

What is the current status of trial NCT01908166?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2014-01. Estimated completion is 2016-11-01.

What interventions are being tested in trial NCT01908166?

The interventions under investigation include: ultrasound elasticity imaging (PROCEDURE).

Who is sponsoring clinical trial NCT01908166?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01908166's enrollment target sits among peer trials

61 1164th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01908166, the US trial registry maintained by the National Library of Medicine. NCT01908166 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.